Korean J Urol Oncol.  2019 Apr;17(1):60-65. 10.22465/kjuo.2019.17.1.60.

Serial Comparison of Cancer Detection Rate Between Transrectal Ultrasound Sonography Guided Biopsy and Magnetic Resonance Imaging for Repeat Biopsy by a Propensity Score Matching Cohort: A Single Center Experience

• Bang S
• Choi YH
• Kang M
• Jeon HG
• Jeong BC
• Seo SI
• Jeon SS
• Kim CK
• Park BK
• Lee HM

• KMID: 2448928
• DOI: http://doi.org/10.22465/kjuo.2019.17.1.60

Abstract

PURPOSE
To compare biopsy performance of 2 approaches for multiparametric magnetic resonance imaging (MRI) guided biopsy and transrectal ultrasonography (TRUS)-guided biopsy with 2nd and 3rd repeat biopsy patients in prostate cancer detection.
MATERIALS AND METHODS
This retrospective study reviewed 2,868 patients who was performed prostate biopsy between September 2013 to March 2017 at Samsung Medical Center, Seoul, Korea with TRUS-guided random biopsy and MRI fusion, MRI cognitive, and MRI-guided biopsy as 2nd and 3rd repeat biopsy and propensity matching was applied to reduce bias. Detection rate of each study was compared with 1:1 matching.
RESULTS
Among 265 patients who performed TRUS 2nd biopsy, positivity rate for prostate cancer (PCa) was 18.49% (n=49/265) while 54.72% (n=145/265) for MRI-guided biopsy. In 3rd biopsy, positivity rate for PCa of TRUS biopsy was 17.74% (n=11/62) while 56.45% (n=35/62) for MRI guided biopsy. There was no significant difference in the detection rate for the patient with Gleason score 8 or more.
CONCLUSIONS
MRI-guided biopsy was associated with a higher detection rate of prostate cancer with especially in patients with prior negative biopsy.

Keyword

Prostatic neoplasm; Repeat biopsy; Magnetic resonance imaging; Transrectal ultrasonography; Outcome

MeSH Terms

Bias (Epidemiology)
Biopsy*
Cohort Studies*
Humans
Korea
Magnetic Resonance Imaging*
Neoplasm Grading
Passive Cutaneous Anaphylaxis
Propensity Score*
Prostate
Prostatic Neoplasms
Retrospective Studies
Seoul
Ultrasonography*